Team

 

SV Life Sciences has a team of 34 professionals, of which 27 are deal professionals focusing on our portfolio; identifying investment opportunities, structuring and executing transactions, actively working with portfolio companies on development and growth initiatives and achieving investment realizations. The remaining seven team members are finance professionals who provide essential support to the deal teams and our investors. A key strength of the SV Life Sciences team is the breadth of hands-on operational experience in venture capital investment as well as within the Life Sciences industry across operational, scientific and clinical experience.  

 

 

Venture Partners

Houman Ashrafian
Houman Ashrafian
Therapeutics
Graham Boulnois
Graham Boulnois
Biotechnology
Daniel Burgess
Daniel Burgess
Biotechnology
Michael Carter
Michael Carter
Biotechnology
Bruce Cerullo
Bruce Cerullo
Healthcare
Tillman Gerngross
Tillman Gerngross
Biotechnology
Jim Glynn
Jim Glynn
Healthcare
David Guyer
David Guyer
Biotechnology
Tim Harris
Tim Harris
Biotechnology
Michael Mendelsohn
Michael Mendelsohn
Biotechnology
David Milne
David Milne
Medical Devices
Bob Palmisano
Bob Palmisano
Medical Devices
Bruce A Peacock
Bruce A Peacock
Biotechnology
James C. Walker
James C. Walker
Healthcare


⇧ Back to top